Aptevo Therapeutics
APVO
APVO
hedge funds and large institutions have $2.63M invested in Aptevo Therapeutics in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$855K | |
| 2 | -$524K | |
| 3 | -$283K | |
| 4 |
Renaissance Technologies
New York
|
-$250K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$189K |